0002107166
Company

RWB Health Inc.

Retail-Nonstore Retailers · RWB

ipo amended S-1/A

Filing Timeline

SEC EDGAR
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
RWB Health, Inc. is a newly incorporated company focused on selling CBD products in North America, with an exclusive license to distribute Natures Life CBD products. The company is offering 3,000,000 shares of common stock at $0.025 per share, aiming to raise up to $75,000. The offering is self-underwritten with a 90-day duration, extendable by the sole officer, Gabriel Voinea. The company has limited operational history, minimal revenues, and a going concern uncertainty. It plans to expand its product offerings and establish its own brand but faces significant risks including market dependence, financial instability, and lack of liquidity.
2026-03-26 · 0001477932-26-001605
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
RWB Health, Inc. is a newly organized Nevada company (incorporated Oct. 10, 2025) seeking to register a self-underwritten primary offering of 3,000,000 shares of common stock at $0.025 per share for up to $75,000 gross proceeds, offered for 90 days from the effective date (potentially extendable by another 90 days at the board’s discretion). The company plans to sell CBD products in North America primarily under an exclusive license (including Canada, Mexico, and the United States) and to have non-exclusive global rights, with an initial 5-year term and automatic renewal absent termination notice. Business operations include direct-to-consumer sales via its website and wholesale distribution to other channels; it currently sells Natures Life brand products and intends to expand offerings over time. Financially, for the period from inception through Dec. 31, 2025, it reports $8,940 revenues and $1,690 net income, and its independent auditor’s opinion includes substantial doubt about the company’s ability to continue as a going concern. The filing indicates no existing public trading market; the company plans to seek OTCQB/Venture Market trading via a FINRA market maker application but does not yet have a market maker. The company is an “emerging growth company” and anticipates using related reporting accommodations.
2026-02-20 · 0001477932-26-000942
Comparable Deals
Not enough completed IPOs with similar characteristics to show comparables yet.

Recent News

No recent news stored for this issuer.